Apixaban and Acenocoumarol: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Acenocoumarol
No brand names on recordApixaban
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these drugs are blood thinners. Acenocoumarol works like warfarin, and apixaban (Eliquis) blocks a clotting factor called factor Xa. When you take them together, their effects add up, so your blood becomes thinner than it should be. That raises your risk of serious bleeding, which in rare cases can be dangerous.
Please watch for warning signs like unusual bruising, pink or red urine, black or bloody stools, nosebleeds that won't stop, or bleeding gums. If you notice heavy bleeding, get emergency help right away. The good news is your care team can manage this safely by carefully planning your medicines and monitoring you. Talk with your doctor or pharmacist before making any changes.
Additive anticoagulation. Acenocoumarol (a vitamin K antagonist reducing synthesis of factors II, VII, IX, X) plus apixaban (a direct factor Xa inhibitor) produce a purely pharmacodynamic additive effect, increasing bleeding risk. This is not a prodrug or CYP-mediated PK interaction.
- Direction: increased anticoagulant effect / bleeding risk.
- Magnitude: PD interaction studies with apixaban plus enoxaparin showed a 50 to 60% rise in anti-FXa activity.
- Evidence: probable; severity: major.
- Management: concurrent use is generally avoided except during bridging/transition. Apixaban PD effect persists at least 24 hours after the last dose. Educate on bleeding signs; if active pathological bleeding occurs, discontinue apixaban, consider reversal agent, PCC, aPCC, or rFVIIa.
What happens
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
Giving apixaban, an inhibitor of factor Xa, together with another anticoagulant raises the likelihood of bleeding. Pharmacodynamic drug interaction studies of apixaban demonstrated a 50% to 60% rise in anti-factor Xa activity when apixaban and enoxaparin were administered concurrently. If active pathological bleeding develops, apixaban should be stopped. There is an agent available that reverses the anti-factor Xa activity of apixaban. The pharmacodynamic action of apixaban is anticipated to remain for a minimum of 24 hours following the final dose. Patients should be counseled about the signs and symptoms of blood loss, instructed to report them without delay, or to present to an emergency room. Prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa may be considered as options. If PCCs are administered, using a clotting assay (PT, INR, or aPTT) or anti-factor Xa (FXa) activity to monitor apixaban's anticoagulant effect provides no benefit and is not advised. Activated charcoal taken orally decreases the absorption of apixaban, which in turn reduces apixaban exposure1.
Why it happens (mechanism)
Additive anticoagulation
How to manage this interaction
Keep taking both exactly as prescribed unless your doctor tells you otherwise. These two blood thinners are usually not used together long term, so your care team may plan a careful transition from one to the other, with dosing and timing individualized to you.
- Learn the signs of bleeding: unusual bruising, blood in urine or stool, black stools, prolonged nosebleeds, coughing or vomiting blood.
- Report bleeding right away, or go to an emergency room for heavy or uncontrolled bleeding.
- Remember apixaban's effect can last at least 24 hours after the last dose.
- Ask your pharmacist or prescriber before starting, stopping, or changing either drug.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) During investigations of pharmacodynamic drug interactions involving apixaban, an increase of 50% to 60% in anti-factor Xa activity was noted when apixaban and enoxaparin were given together 1.
Common questions
Can I take Apixaban and Acenocoumarol together?
Acenocoumarol and apixaban are both blood thinners, so taking them together adds up and raises the risk of serious bleeding. Do not change anything on your own; let your care team plan and monitor any use or transition, and get help right away if you notice bleeding. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Apixaban and Acenocoumarol interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Apixaban and Acenocoumarol interaction managed?
Keep taking both exactly as prescribed unless your doctor tells you otherwise. These two blood thinners are usually not used together long term, so your care team may plan a careful transition from one to the other, with dosing and timing individualized to you. Learn the signs of bleeding: unusual bruising, blood in urine or stool, black stools, prolonged nosebleeds, coughing or vomiting blood. Re… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Apixaban or Acenocoumarol need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Keep reading about Acenocoumarol
Keep reading about Apixaban
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist